The UN health agency said the deadly attack in Idlib province yesterday appeared to have involved chemical weapons, pointing to the "apparent lack of external injuries reported in cases showing a rapid onset of similar symptoms, including acute respiratory distress as the main cause of death."
"Some cases appear to show additional signs consistent with exposure to organophosphorus chemicals, a category of chemicals that includes nerve agents," it said.
At least 72 civilians, among them 20 children, were killed in yesterday's attack in rebel-held Khan Sheikhun, and dozens more were left gasping for air, convulsing, and foaming at the mouth, doctors said.
But WHO said there was good reason to suspect a chemical attack, noting the dozens of patients admitted to hospitals "suffering from breathing difficulties and suffocation."
"The images and reports coming from Idlib today leave me shocked, saddened and outraged," Peter Salama, head of WHO's health emergencies programme, said in a statement.
"These types of weapons are banned by international law because they represent an intolerable barbarism," he added.
WHO warned that the capacity of hospitals in the surrounding area was limited and that many facilities had been damaged in the fighting.
Emergency rooms in the area were overwhelmed, and many patients had been referred to southern Turkey, it said.
As soon as word got out about the suspected chemical attack, WHO said it had begun dispatching medicines, including Atrophine, an antidote for some types of chemical exposure, and steroids for symptomatic treatment, from a warehouse in Idlib.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
